Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 1 Jan 2017

Chen Lujun, Xiong Yuqi, Li Jing, Zheng Xiao, Zhou Qi, Turner Abbey, Wu Changping, Lu Binfeng, Jiang Jingting

Abstract excerpt

BACKGROUND/AIMS: PD-L1 (Programmed cell death 1 ligand 1, PD-L1), an essential immune checkpoint molecule in the tumor microenvironment, is an important target for cancer immunotherapy. We have previously reported that its expression in human gastric and esophageal cancer tissues is significantly associated with cancer progression and patients' postoperative prognoses. Its expression in cancer cells is well known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Cadherins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Survival

Share to Epithelial-Mesenchymal Transition

Share to Esophageal Neoplasms

Share to Programmed Cell Death 1 Receptor

Share to RNA, Small Interfering

Share to Vimentin

Source

Identifiers

PMID: 28848143
DOI: 10.1159/000480000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer.PMID 28848143Read ↗

PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.Semantic proximity Read ↗

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.Semantic proximity Read ↗

Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)Semantic proximity Read ↗

Esophageal cancer-derived exosomes imbalance Tfh/Tfr cell ratio in the tumor immune microenvironment via EXO-PDL1 to promote immunosuppressionSemantic proximity Read ↗

Esophageal cancer derived exosomes imbalance circulating Tfh/Tfr via EXO-PDL1 to promote immunosuppressionSemantic proximity Read ↗

New insights into the important roles of tumor cell-intrinsic PD-1Semantic proximity Read ↗

Analysis of the crosstalk between EMT-related gene and Tumor-infiltrating immune cell in Esophageal Squamous Cell CarcinomaSemantic proximity Read ↗

The glioma-associated oncogene homolog 1 promotes epithelial–mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via SnailSemantic proximity Read ↗

PD-L1: expression regulationSemantic proximity Read ↗

Regulatory role of programmed cell death 4 in precancerous gastric lesions and early gastric cancerSemantic proximity Read ↗

TRAIL Promotes Epithelial-to-mesenchymal Transition by Inducing PD-L1 Expression in Esophageal Squamous Cell CarcinomasSemantic proximity Read ↗

Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.